DiaMedica Therapeutics (DMAC) P/E (2018 - 2026)
DiaMedica Therapeutics (DMAC) P/E from Dec 31, 2018 to Jul 21, 2026. The TTM DiaMedica Therapeutics (DMAC) P/E is -10.21. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of DiaMedica Therapeutics (DMAC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -10.21 | -11.88% |
| 2025 | -11.59 | +25.22% |
| 2024 | -9.26 | +87.96% |
| 2023 | -4.92 | +55.32% |
| 2022 | -3.17 | -47.29% |
| 2021 | -6.01 | -56.10% |
| 2020 | -13.70 | +150.88% |
| 2019 | -5.46 | -69.24% |
| 2018 | -17.75 | N/A |
Comparison DiaMedica Therapeutics (DMAC) P/E with competitors
DiaMedica Therapeutics (DMAC) P/E is -10.21.